Correlation Between Akoya Biosciences and AptarGroup

Can any of the company-specific risk be diversified away by investing in both Akoya Biosciences and AptarGroup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akoya Biosciences and AptarGroup into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akoya Biosciences and AptarGroup, you can compare the effects of market volatilities on Akoya Biosciences and AptarGroup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akoya Biosciences with a short position of AptarGroup. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akoya Biosciences and AptarGroup.

Diversification Opportunities for Akoya Biosciences and AptarGroup

0.15

Correlation Coefficient

Akoya Biosciences  AptarGroup

Average diversification

The 3 months correlation between Akoya and AptarGroup is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Akoya Biosciences and AptarGroup in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptarGroup and Akoya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akoya Biosciences are associated (or correlated) with AptarGroup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptarGroup has no effect on the direction of Akoya Biosciences i.e., Akoya Biosciences and AptarGroup go up and down completely randomly.

Pair Corralation between Akoya Biosciences and AptarGroup

Given the investment horizon of 90 days Akoya Biosciences is expected to generate 6.1 times less return on investment than AptarGroup. In addition to that, Akoya Biosciences is 5.5 times more volatile than AptarGroup. It trades about 0.01 of its total potential returns per unit of risk. AptarGroup is currently generating about 0.22 per unit of volatility. If you would invest  14,964  in AptarGroup on September 3, 2024 and sell it today you would earn a total of  2,312  from holding AptarGroup or generate 15.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Akoya Biosciences  vs.  AptarGroup

Akoya Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akoya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Akoya Biosciences is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

AptarGroup

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in AptarGroup are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, AptarGroup reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Akoya Biosciences and AptarGroup

The main advantage of trading using opposite Akoya Biosciences and AptarGroup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akoya Biosciences position performs unexpectedly, AptarGroup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptarGroup will offset losses from the drop in AptarGroup's long position.

The idea behind Akoya Biosciences and AptarGroup pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.